Twist Bioscience Sees AI Drug Discovery Pipeline Expand
Twist Bioscience (NASDAQ: TWST) stock is up on strong Q3 results and raised guidance. AI drug discovery and NGS businesses show growth.
Twist Bioscience did better than expected this quarter and says it will do even better ahead, because their AI tools for finding new medicines are working well. When a company beats expectations and raises its outlook, it usually means the business is moving in the right direction—so watch if they keep delivering on those promises.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.